Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $3 |
| % Growth | 2.2% | -14.7% | -28.2% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $1 | $1 | $1 | $2 |
| % Margin | 65.3% | 69.6% | 68.2% | 80% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $1 | $0 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | -$0 | -$0 | $1 | -$0 |
| Operating Expenses | $1 | $1 | $3 | $2 |
| Operating Income | -$0 | $0 | -$2 | $1 |
| % Margin | -7.3% | 8.7% | -83.9% | 25.4% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$2 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$2 | $0 |
| % Margin | -11.4% | -2.9% | -87.8% | 13.7% |
| EPS | -0.023 | -0.006 | -0.21 | 0.044 |
| % Growth | -303.4% | 97.2% | -575.1% | – |
| EPS Diluted | -0.023 | -0.006 | -0.21 | 0.044 |
| Weighted Avg Shares Out | 9 | 9 | 9 | 9 |
| Weighted Avg Shares Out Dil | 9 | 9 | 9 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | -$2 | $1 |
| % Margin | 5.5% | 18% | -70.7% | 30.7% |